The prognosis of pediatric headaches--a 30-year follow-up study

Joseph M Dooley1, Haley F Augustine1, Paula M Brna1

  • 1Department of Pediatrics, Pediatric Neurology Division, Dalhousie University, Halifax, Nova Scotia, Canada.

Pediatric Neurology
|May 13, 2014
PubMed

Insights

Childhood headaches often persist into adulthood, with about 70% of individuals still experiencing them 30 years post-diagnosis. Simple management strategies like analgesia and avoiding triggers show long-term benefits for headache sufferers.

Area of Science:

  • Pediatric Neurology
  • Longitudinal Health Studies

Background:

  • Childhood headaches are prevalent but lack extensive long-term prognosis data.
  • A cohort of patients diagnosed with headaches in 1983 has been monitored for long-term outcomes.

Purpose of the Study:

  • To investigate the long-term prognosis of headaches in children.
  • To analyze headache characteristics and effective management strategies over 30 years.

Main Methods:

  • A 30-year follow-up study involving 28 of 60 initial patients (47% participation).
  • Data collected via standardized telephone interviews, gathering details on headache patterns, triggers, relief factors, and management techniques.

Main Results:

  • Complete headache resolution was reported by 29% of patients over 30 years.
  • Headache types varied significantly over time; only 3 patients maintained the same type.
  • Nonprescription analgesia, trigger avoidance, and self-relaxation were the most common management strategies.

Conclusions:

  • Approximately 70% of childhood headaches persist 30 years after initial diagnosis.
  • Management through simple analgesia and precipitant avoidance demonstrates long-term efficacy.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
409
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial...
20
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins...
19
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
405
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component...
27